Abcam have created panels of immuno-oncology (IO)-relevant antibody that have been optimized for use in immunohistochemistry (IHC). Each hand-picked panel is made up of 2–6 anti-human monoclonal antibodies to the same protein.

The range includes key immune checkpoint targets like PD-L1, TIM-3, CTLA-4, immune-phenotyping markers and established oncology targets. These panels contain multiple trial-sized vials of antibodies and are priced the same as a single full-sized RabMAb® antibody.

Click here to get access to the best selection of IO clones on the market!